Nantahala Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001472322

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2026 · 153 positions · Total reported value $2.18B · Top-10 concentration 29.0% · Updated 2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

Turnover: 34.3% · 25 new · 19 cut · 13 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.9% · vs SPY -5.1% · Prev Value $2.49B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.3% · vs SPY -4.5% · Latest Value $2.18B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Nantahala Capital Management, LLC disclosed 153 equity positions with a combined reported value of $2.18B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 29.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were XBI ($110.38M), BVS ($87.52M), TBBK ($70.57M). By sector, the heaviest allocations are Health Care 59.6%, Consumer Discretionary 16.8%. Versus the prior quarter, allocation shifted toward Health Care (+8.6pp), Financials (+4.6pp) and away from Industrials (-0.9pp), Other (-17.1pp).

Versus the prior quarter, Nantahala Capital Management, LLC opened 25 new positions, trimmed 19 and fully exited 13, a turnover rate of 34.3% of positions. The portfolio's overlap with the prior quarter was 77% of names.

The largest new positions opened in Q3 2026 were KRE ($69.44M), RARE ($35.16M), DLB ($29.39M).

Of the 13 positions fully exited versus the prior quarter, the largest were ITGR ($10.40M), AMLX ($8.74M), QURE ($7.44M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • KRE SPDR SERIES TRUST · $69.44M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · $35.16M
  • DLB DOLBY LABORATORIES INC · $29.39M
  • VRDN VIRIDIAN THERAPEUTICS INC · $16.47M
  • RACC RESEARCH ALLIANCE CORP III · $11.91M
  • ATOS ATTOVIA THERAPEUTICS INC · $9.62M
  • ENTX ENTERA BIO LTD · $8.74M
  • DYN DYNE THERAPEUTICS INC · $6.16M

Fully Exited (vs previous quarter)

  • ITGR INTEGER HLDGS CORP · prev qtr: $10.40M
  • AMLX AMYLYX PHARMACEUTICALS INC · prev qtr: $8.74M
  • QURE UNIQURE NV · prev qtr: $7.44M
  • TRAX FIRST TRACKS BIOTHERAPEUTICS · prev qtr: $5.03M
  • RLYB RALLYBIO CORP · prev qtr: $3.01M
  • TRDA ENTRADA THERAPEUTICS INC · prev qtr: $2.21M
  • ALXO ALX ONCOLOGY HLDGS INC · prev qtr: $1.55M
  • BRCC BRC INC · prev qtr: $1.40M

Insider Transactions (Form 4)

Latest Nantahala Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Nantahala Capital Management, LLC is an SEC-registered 13F filer based in New Canaan, CT, United States. As of Q2 2026 it reported 141 US equity positions with a combined value of $2.49B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW CANAAN, CT, United States
  • SEC registration: 801-72481 (status: Approved), registered 2011-06-24
  • Regulatory AUM (Form ADV): $3.11B as of 2026-09-14
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: nantahalapartners.com

Portfolio Structure

  • 141 positions · $2.49B reported value (Q2 2026)
  • Top 10 holdings = 43.8% of reported value
  • Largest position: IWM (ISHARES TR) at 24.1%
  • Average position size: $17.65M

Sector Tilt

  • Health Care 51.0%
  • Consumer Discretionary 14.7%
  • Financials 2.5%
  • (classified holdings cover 71% of value)

Quarterly Activity

  • Q2 2026: 24 new, 23 added, 38 reduced, 20 exited
  • 56 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is aggressively expanding its biotech/health care exposure (7/10 top holdings) while adding new positions (KRE) and significantly increasing stakes in high-growth names (TBBK +1064.8% QoQ, PTON +77.0% QoQ), suggesting a bullish view on specialized sectors and potential undervaluation. 2. Key moves: - Added: XBI (biotech ETF, +75% shares), BVS (Bioventus, +7%), TBBK (Bancorp, +1064.8%), EOLS (Evolutus, +11.5%), PTON (Peloton, +77%), LBRX (LB Pharmaceuticals, +2%). - Reduced: ETON (Eton Pharmaceuticals, -25.5% shares), AMRX (Amneal Pharmaceuticals, -6.7%). - New: KRE (regional bank ETF). 3. Portfolio structure: Highly active, concentrated in health care (70%+ top holdings), with appetite for volatile, high-growth small/mid-caps and sector-specific ETFs (XBI, KRE). 4. Per-holding one-liner: - XBI: Biotech ETF (SPDR). - BVS: Medical device company (Bioventus). - TBBK: Regional bank (Bancorp). - KRE: Regional bank ETF (SPDR). - EW: Medical tech (Edwards Lifesciences). - EOLS: Dermatology drug developer (Evolutus). - PTON: Fitness equipment (Peloton). - ETON: Dermatology drug developer (Eton Pharmaceuticals). - AMRX: Generic drugmaker (Amneal Pharmaceuticals). - LBRX: Dermatology drug developer (LB Pharmaceuticals). 5. Style summary: Aggressive biotech/health care tilt with concentrated bets on high-growth small-caps and sector ETFs, favoring additions over reductions.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-16 13:41

Sector Allocation

Health Care 59.6%
Financials 7.1%
Technology 1.9%
Materials 0.8%
Other 11.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 700.00K $110.38M 5.07%
5.07%
Add
2 6.42M $87.52M 4.02%
4.02%
Add
3 1.47M $70.57M 3.24%
3.24%
Add
4 1.00M $69.44M 3.19%
3.19%
New
5 800.00K $69.06M 3.17%
3.17%
Hold
6 6.24M $49.96M 2.29%
2.29%
Add
7 9.04M $45.13M 2.07%
2.07%
Add
8 875.51K $45.08M 2.07%
2.07%
Reduce
9 2.12M $42.61M 1.96%
1.96%
Reduce
10 1.07M $41.23M 1.89%
1.89%
Add
11 140.30K $40.86M 1.88%
1.88%
Add
12 1.17M $40.71M 1.87%
1.87%
Add
13 7.14M $36.83M 1.69%
1.69%
Add
14 5.51M $36.17M 1.66%
1.66%
Hold
15 2.34M $35.16M 1.61%
1.61%
New
16 223.00K $33.81M 1.55%
1.55%
Hold
17 2.14M $32.84M 1.51%
1.51%
Add
18 6.91M $32.20M 1.48%
1.48%
Add
19 220.40K $31.26M 1.44%
1.44%
Add
20 500.00K $29.39M 1.35%
1.35%
New
21 440.56K $28.27M 1.30%
1.30%
Add
22 85.00K $28.27M 1.30%
1.30%
Hold
23 1.14M $26.26M 1.21%
1.21%
Hold
24 2.59M $25.98M 1.19%
1.19%
Add
25 4.80M $25.92M 1.19%
1.19%
Add
26 733.68K $25.61M 1.18%
1.18%
Add
27 6.58M $24.33M 1.12%
1.12%
Add
28 68.39M $24.29M 1.11%
1.11%
Hold
29 11.21M $24.11M 1.11%
1.11%
Add
30 3.81M $23.91M 1.10%
1.10%
Add
31 31.14K $23.61M 1.08%
1.08%
Reduce
32 1.73M $22.88M 1.05%
1.05%
Hold
33 1.25M $22.65M 1.04%
1.04%
Add
34 1.85M $22.41M 1.03%
1.03%
Add
35 4.57M $22.12M 1.01%
1.01%
Add
36 1.96M $21.54M 0.99%
0.99%
Add
37 2.76M $21.44M 0.98%
0.98%
Reduce
38 293.03K $20.32M 0.93%
0.93%
Add
39 198.75K $19.68M 0.90%
0.90%
Add
40 1.75M $19.40M 0.89%
0.89%
Add
41 2.24M $17.82M 0.82%
0.82%
Add
42 931.64K $17.78M 0.82%
0.82%
Add
43 662.90K $17.66M 0.81%
0.81%
Add
44 707.14K $17.64M 0.81%
0.81%
Add
45 2.10M $17.50M 0.80%
0.80%
Add
46 689.84K $17.34M 0.80%
0.80%
Reduce
47 13.87M $17.06M 0.78%
0.78%
Add
48 1.49M $16.99M 0.78%
0.78%
Add
49 1.68M $16.78M 0.77%
0.77%
Add
50 1.20M $16.47M 0.76%
0.76%
New

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 60% R 60% F1 60% (modelled on 2026-Q2; 6/10 hit)

Low-confidence forecast This fund replaces about 33% of its Top-10 each quarter and backtests at F1 66% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 66% · recall 66% · F1 66% · avg rank error 3.3 · Top-10 turnover 33%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 60% 60% 60% XBI · SLNO · CASH · COST · RDNW · EOLS · BVS · CRMT · RDVT · IWM IWM · SLNO · LLY · LOPE · CASH · COST · EOLS · IMAX · HGV · BVS
2024-Q2 60% 60% 60% IWM · SLNO · LLY · LOPE · COST · CASH · EOLS · IMAX · HGV · RDNW LLY · SLNO · ESTA · LOPE · EOLS · BVS · CASH · HGV · PTON · SVRA
2024-Q3 80% 80% 80% LLY · ESTA · SLNO · LOPE · EOLS · HGV · PTON · BVS · CASH · SVRA SLNO · ESTA · LLY · LOPE · BVS · EOLS · SYK · PTON · TBBK · HGV
2024-Q4 90% 90% 90% SLNO · ESTA · LLY · LOPE · BVS · EOLS · PTON · SYK · TBBK · HGV SLNO · LLY · XBI · ESTA · HGV · TBBK · PTON · BVS · SYK · EOLS
2025-Q1 50% 50% 50% SLNO · XBI · LLY · HGV · ESTA · TBBK · PTON · BVS · EOLS · SYK HYG · QQQ · XBI · ESTA · TBBK · SLNO · BVS · AMRX · GOGO · CRMT
2025-Q2 60% 60% 60% HYG · QQQ · XBI · ESTA · TBBK · SLNO · BVS · GOGO · AMRX · QURE IWM · SLNO · ESTA · XBI · TBBK · XTNT · VTRS · CRMT · AMRX · BVS
2025-Q3 60% 60% 60% IWM · SLNO · ESTA · XBI · XTNT · TBBK · VTRS · CRMT · BVS · AMRX IWM · EW · ESTA · XBI · TBBK · QURE · TEVA · VTRS · ABVX · XTNT
2025-Q4 70% 70% 70% IWM · EW · ESTA · XBI · TBBK · TEVA · QURE · XTNT · VTRS · ABVX EW · TEVA · TBBK · ESTA · VTRS · XTNT · XBI · FULC · HGV · BVS
2026-Q1 70% 70% 70% EW · TEVA · TBBK · ESTA · VTRS · XTNT · HGV · FULC · XBI · BVS IWM · VTRS · EW · BVS · PTON · ESTA · TEVA · HGV · SVRA · XBI
2026-Q2 60% 60% 60% IWM · VTRS · EW · PTON · BVS · HGV · ESTA · TEVA · GOGO · SVRA IWM · VTRS · EW · XBI · BVS · HGV · SVRA · ETON · AMRX · EOLS
2026-Q3 ★ 60% 60% 60% IWM · VTRS · EW · XBI · BVS · HGV · SVRA · ETON · AMRX · EOLS XBI · BVS · TBBK · KRE · EW · EOLS · PTON · ETON · AMRX · LBRX

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-13. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-13 Trading days32 Holdings9 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.

Portfolio return+9.24%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+22.96%vs benchmark
Barra annualised vol39.0%Model estimate
Realised vol28.5%Annualised in window
Weighted beta1.29Raw exposure
Factor / specific risk56% / 44%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)77.886.795.6104.5113.410-0110-2311-13Nantahala Capital Management, LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+9.24%Disclosed long book
QQQ synthetic benchmark-13.72%Liquidity-weighted constituents
Model universe, equal weight+0.30%Opportunity-cost reference
Excess return+22.96%Portfolio − benchmark
Arithmetic return sum+9.36%Difference vs compounded is the cross term
Weighted raw beta1.29Weighted holding betas
Realised volatility (annualised)28.52%Daily returns in window
Barra model volatility (annualised)38.96%Factor + specific
Factor share of variance56.1%Barra factors
Specific share of variance43.9%Stock residuals
Reported value$157.6M13F long US equity

2. Return attribution

The +9.36% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -6.40% -68.4%
Momentum & Growth 3 -0.21% -2.3%
Volatility & Tail Risk 7 -0.06% -0.7%
Industry 12 +7.09% 75.8%
Specific 1 +8.94% 95.5%
Return attribution (style + industry, %)-9.4-4.7+0.0+4.7+9.4Amihud Illiquidity-0.82Kurtosis+1.19Skewness+1.38Leverage (Downside Vol)-1.54Max Drawdown+1.88Non-linear Size+2.04Beta+2.11Size+2.17Consumer Discretionary+3.24Mid Cap-3.25Health Care+3.37Residual Volatility+3.65Turnover-6.50Historical Volatility-8.73
Factor Type Exposure Factor return Contribution Share of |return|
Specific Specific — — +8.94% 95.5%
Residual Volatility Style +1.37 +2.66% +3.65% 39.0%
Health Care Industry +0.41 +8.12% +3.37% 36.0%
Consumer Discretionary Industry +0.41 +7.85% +3.24% 34.6%
Size Style -1.19 -1.83% +2.17% 23.2%
Beta Style +0.44 +4.85% +2.11% 22.6%
Non-linear Size Style +2.24 +0.91% +2.04% 21.9%
Max Drawdown Style -0.96 -1.96% +1.88% 20.1%
Skewness Style -0.33 -4.21% +1.38% 14.7%
Kurtosis Style +0.17 +6.97% +1.19% 12.7%
Other Industry +0.06 +10.06% +0.61% 6.5%
Short-term Reversal Style +0.44 +0.79% +0.34% 3.7%
Momentum Style +0.02 -3.34% -0.07% -0.7%
Financials Industry +0.11 -1.13% -0.13% -1.4%
Growth Style -0.31 +1.57% -0.49% -5.2%
Amihud Illiquidity Style +2.03 -0.40% -0.82% -8.8%
Leverage (Downside Vol) Style +0.84 -1.82% -1.54% -16.4%
Mid Cap Style +1.92 -1.69% -3.25% -34.8%
Turnover Style +1.36 -4.77% -6.50% -69.5%
Historical Volatility Style +0.68 -12.86% -8.73% -93.3%

3. Risk attribution

Annualised volatility is 38.96%; factor risk explains 56.1% of variance and specific risk 43.9%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-47.4-23.7+0.0+23.7+47.4Amihud Illiquidity+1.37Other+1.61Turnover+1.64Beta+1.89Financials+1.92Leverage (Downside Vol)+3.55Max Drawdown+4.02Size+4.66Non-linear Size+5.75Health Care+5.95Historical Volatility+6.72Consumer Discretionary+7.51Mid Cap+10.54Specific+43.88
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 43.9% +17.09% 17.1%
Mid Cap Style +1.92 10.5% +4.11% 4.1%
Consumer Discretionary Industry +0.41 7.5% +2.93% 2.9%
Historical Volatility Style +0.68 6.7% +2.62% 2.6%
Health Care Industry +0.41 6.0% +2.32% 2.3%
Non-linear Size Style +2.24 5.8% +2.24% 2.2%
Size Style -1.19 4.7% +1.82% 1.8%
Max Drawdown Style -0.96 4.0% +1.57% 1.6%
Leverage (Downside Vol) Style +0.84 3.5% +1.38% 1.4%
Financials Industry +0.11 1.9% +0.75% 0.8%
Beta Style +0.44 1.9% +0.74% 0.7%
Turnover Style +1.36 1.6% +0.64% 0.6%
Other Industry +0.06 1.6% +0.63% 0.6%
Amihud Illiquidity Style +2.03 1.4% +0.53% 0.5%
Residual Volatility Style +1.37 0.9% +0.34% 0.3%
Short-term Reversal Style +0.44 -0.4% -0.17% -0.2%
Kurtosis Style +0.17 -0.5% -0.19% -0.2%
Skewness Style -0.33 -1.1% -0.45% -0.5%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.5-0.50.51.62.6Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -1.19 +2.10 -3.29
Non-linear Size +2.24 +1.68 +0.56
Mid Cap +1.92 +0.13 +1.79
Beta +0.44 +1.29 -0.86
Momentum +0.02 +0.72 -0.70
Short-term Reversal +0.43 -0.64 +1.08
Residual Volatility +1.37 -0.40 +1.77
Historical Volatility +0.68 +0.86 -0.18
Liquidity -0.20 +0.11 -0.31
Amihud Illiquidity +2.03 +1.16 +0.87
Turnover +1.36 +0.21 +1.16
Growth -0.31 +0.58 -0.90
Leverage (Downside Vol) +0.84 +0.14 +0.70
Skewness -0.33 +0.24 -0.56
Kurtosis +0.17 +0.21 -0.04
Max Drawdown -0.96 -0.08 -0.88

5. Industry allocation & Brinson

Industry allocation (weight, %)-7.414.736.858.981.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesIndustrialsOtherFinancialsConsumer DiscretionaryHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -19.18% +4.32% +14.12% -14.12% +14.12%
Consumer Discretionary 41.3% 8.8% +20.85% +5.56% +6.12% +1.35% +4.96% +8.11%
Financials 11.2% 0.0% +25.94% +0.00% +1.49% +0.00% +2.91% +2.91%
Communication Services 0.0% 2.6% +0.00% -15.54% +0.06% +0.41% -0.41% +0.41%
Other 6.1% 0.0% +1.24% +0.00% +0.81% +0.00% +0.08% +0.08%
Utilities 0.0% 0.8% +0.00% +11.58% -0.20% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.58% -0.24% -0.13% +0.13% -0.13%
Industrials 0.0% 11.1% +0.00% +7.16% -2.27% -0.80% +0.80% -0.80%
Health Care 41.5% 1.7% -2.44% +9.16% +8.93% -0.20% -4.61% -1.17%
Total +18.92% +14.62% -10.14% +23.40%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
PTON PELOTON INTERACTIVE INC Consumer Discretionary 28.64% +14.23% +4.08% Add
REGN REGENERON PHARMACEUTICALS Health Care 14.99% +26.01% +3.90% Reduce
AGMB AGOMAB THERAPEUTICS NV Health Care 12.31% -42.70% -5.26% Add
CHYM CHIME FINL INC Financials 11.21% +25.94% +2.91% Add
TNGX TANGO THERAPEUTICS INC Health Care 11.20% +2.20% +0.25% Add
PLNT PLANET FITNESS MASTER ISSUER Consumer Discretionary 9.21% +44.91% +4.13% Add
IWM ISHARES TR Other 6.08% +1.24% +0.07% Reduce
DKS DICKS SPORTING GOODS INC Consumer Discretionary 3.41% +11.47% +0.39% New
SGMT SAGIMET BIOSCIENCES INC Health Care 2.96% +3.44% +0.10% New
Contribution rank Symbol Sector Weight Return Contribution
1 PLNT Consumer Discretionary 9.21% +44.91% +4.13%
2 PTON Consumer Discretionary 28.64% +14.23% +4.08%
3 REGN Health Care 14.99% +26.01% +3.90%
4 CHYM Financials 11.21% +25.94% +2.91%
5 DKS Consumer Discretionary 3.41% +11.47% +0.39%
6 TNGX Health Care 11.20% +2.20% +0.25%
7 SGMT Health Care 2.96% +3.44% +0.10%
8 IWM Other 6.08% +1.24% +0.07%
9 AGMB Health Care 12.31% -42.70% -5.26%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned +9.24%, versus -13.72% for the QQQ synthetic benchmark — an excess of +22.96%.
  2. Return attribution: the largest positive style/industry contributions came from Residual Volatility +3.65%, Health Care +3.37%, Consumer Discretionary +3.24%; the largest drags came from Historical Volatility -8.73%, Turnover -6.50%, Mid Cap -3.25%. Specific (stock-level) return contributed +8.94%.
  3. Risk attribution: Barra model volatility is 38.96% annualised; factor risk explains 56% of variance and specific risk 44%. The largest factor risk sources are Mid Cap 10.5%, Consumer Discretionary 7.5%, Historical Volatility 6.7%.
  4. Style tilt: size -1.19, momentum +0.02, volatility +0.68, liquidity -0.20; the weighted raw beta is 1.29. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+39.7 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +18.92%, selection +14.62% and interaction -10.14%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Nantahala Capital Management, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Nantahala Capital Management, LLC reported 153 equity positions worth $2.18B in aggregate; its largest disclosed positions were XBI ($110.38M), BVS ($87.52M), TBBK ($70.57M).

How large is Nantahala Capital Management, LLC's portfolio?

Nantahala Capital Management, LLC reported $2.18B of long equity holdings across 153 positions as of 2026-Q3. Top-10 holdings account for 29.0% of reported value.

What is Nantahala Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/nantahala-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →